Miller Dieker Syndrome plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Miller Dieker Syndrome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Miller-Dieker Syndrome (MDS), also known as Lissencephaly Type I, is a severe genetic disorder characterized by classical lissencephaly (smooth brain) with distinctive facial features and severe neurological impairment.
Miller Dieker Syndrome plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Miller Dieker Syndrome has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Dobyns WB, et al. Miller-Dieker syndrome: lissencephaly due to deletions in 17p13.3. Neurology. 1993;43(11):2116-2123. PMID:8232934
Hirotsune S, et al. Lis1 is required for cortical development. Neuron. 1998;21(6):1319-1327. PMID:9883725
Liu JS, et al. Molecular genetics of Miller-Dieker syndrome. Brain Dev. 2011;33(7):527-532. PMID:21459462
Cardoso C, et al. The location and type of mutation predict malformation severity in isolated lissencephaly caused by LIS1 or DCX. Neurology. 2000;55(7):855-860. PMID:11061256
Pilz DT, et al. Lissencephaly due to LIS1 and DCX mutations: clinical and genetic aspects. Brain Dev. 2000;22(2):89-93. PMID:10789800